A detailed history of Anb Bank transactions in Glaukos Corp stock. As of the latest transaction made, Anb Bank holds 2,107 shares of GKOS stock, worth $183,014. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,107
Previous 2,040 3.28%
Holding current value
$183,014
Previous $306 Million 32.2%
% of portfolio
0.09%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025

BUY
$96.6 - $161.22 $6,472 - $10,801
67 Added 3.28%
2,107 $207 Million
Q4 2024

May 06, 2025

BUY
$126.42 - $152.67 $257,896 - $311,446
2,040 New
2,040 $306 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.13B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Anb Bank Portfolio

Follow Anb Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Anb Bank with notifications on news.